Navigation Links
Frontier Scientific Services, Inc. Acquires the Assets of ASDI, Inc.
Date:9/13/2011

SALT LAKE CITY, Sept. 13, 2011 /PRNewswire/ -- Effective September 1st, 2011, Frontier Scientific Services, Inc. (FSSI) has acquired the assets of ASDI.

ASDI has been a recognized leader in providing chemical services to pharmaceutical, industrial, and academic clients. These valuable services now provided by FSSI include:

  • Compound library management to include registration, net inventory capture, material analysis, and reformatting to powder or liquid specifications with distribution to most locations worldwide
  • Sample acquisition – sourcing compound identifiers/structures specified and provided in a client specified format
  • Building Block offering - catalog of high quality, diverse intermediates and building blocks available through an online ordering system, allowing for just-in-time delivery of pre-weighed micro-molar quantities
  • Liquid handling – state-of-the-art, climate controlled capabilities including solvation, plate replication, formatting and transfer
  • Analytical services – in house equipment includes NMR, LC-MS, GC-MS
  • Purification/Reclamation – cost-effective services to recapture pure compound to optimize client time from synthesis to screening

"We are pleased to have completed the acquisition of the assets of ASDI Inc.," said W. Tim Miller, President and CEO of Frontier Scientific. "This will allow the Frontier portfolio of companies to broaden our scope and expand our product and service offerings to our pharmaceutical, government and university customer base. The chemical procurement, library management, and analytical services of ASDI will complement our existing chemical building block and molecular biology product offerings."

FSSI is private and will be managed as an independent portfolio company of Frontier Scientific, Inc.

This transaction allows Frontier Scientific to marry its strength, credibility, and financial stability with the services and product offerings of ASDI. The ASDI name will be transitioned out over the next few months with seamless operations to customers. The entire ASDI catalog will still be available, contact information will remain the same, and the company will stay in the same location with the same address.  The legacy of quick and responsive service will be improved with ongoing investments.

About Frontier Scientific, Inc. (FSI)

FSI is a premier source of boronic acid and porphyrin compounds and a chemical developer, manufacturer, and custom research service(s) provider to the pharmaceutical, biotechnology, industrial chemical, government, and academic sectors. FSI specializes in boronic acids, porphyrins, phthalocyanines, ionic liquids, dendrimers, heterocycles and many other chemical building blocks. FSI develops compounds for small molecule drug discovery, SAR studies, and lead optimization. FSI provides catalog products with production quantities generally from the milligram to kilogram scale. FSI is a privately held corporation headquartered in Logan, Utah. (www.frontiersci.com)

This acquisition bolsters the late 2007 FSI acquisition of Echelon Biosciences Inc. (EBI), a Utah-based life science company.  FSI's investment in EBI opened the doors for expanded research with the aim to further the science of lipid cell signaling and critical metabolic enzymes, providing new and viable targets for the development of potential drugs and diagnostics for cancer, diabetes, inflammation, infections, and cardiovascular disease.  Since 1997, EBI has strengthened its commitment to developing novel assays and reagents for lipid research and beyond. (www.echelon-inc.com)

Although a common management team will guide the portfolio companies of Frontier Scientific Services, Frontier Scientific, and Echelon Biosciences, the companies will be run independently yet will offer common products and services where appropriate to best serve its customers.


'/>"/>
SOURCE Frontier Scientific, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Presentations From Recent Heart Rhythm Society Meeting Validate the Safety and Efficacy of Ablation Frontiers Technology in 230 Patients
2. Cardiologists Tackle Next Frontier in Cardiovascular Disease
3. "Scientific Oktoberfest" Draws the Worldwide Leading Researchers in the Field of Chemical Biology to Munich
4. Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board
5. Star Scientific Launches Anatabloc™ Dietary Supplement
6. Adeona Appoints George A. Eby to Scientific Advisory Board
7. Kewaunee Scientific Reports Sales and Earnings For First Quarter
8. Kewaunee Scientific Corporation Declares Quarterly Dividend
9. Star Scientific Files Second-Quarter Financial Report, Updates Progress on Anatabloc™ Product Launch
10. Scientific Presentations at 2011 AAPM/COMP Meeting Highlight TrueBeam® and RapidArc® Radiotherapy Systems From Varian Medical Systems
11. Boston Scientific Announces Favorable Court Ruling Dismissing Securities Fraud Case
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... N.J. , Dec. 3, 2016  Findings ... and safety of CTL019, an investigational chimeric antigen ... (r/r) pediatric and young adult patients with B-cell ... during an oral session at the 58th American ... December 3, 4:00-5:30 p.m.). The global Phase II ...
(Date:12/2/2016)... bioLytical Laboratories, un líder mundial en test rápidos de ... Self Test , a los miembros de la Kenya Pharmaceutical Association. ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ... (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) bioLytical fue invitada por la Clinton ...
(Date:12/2/2016)... According to the latest market report ... Automated Endoscope Reprocessors: Single Basin Automated Endoscope Reprocessors Product Type ... and 2024 " the global automated endoscope reprocessors market was valued at US$ ... a CAGR of 7.2% during an eight-year forecast period 2016-2024, ... 2024. ...
Breaking Medicine Technology:
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through a comprehensive series of education programs, outreach ... in New York City, with long-time partners The Paul Foundation, on November 10, ...
(Date:12/4/2016)... ... 04, 2016 , ... "Pro3rd Displace is a set of ... displacement design elements," said Christina Austin - CEO of Pixel Film Studios. ... of design styles that include both left aligned and right aligned options for ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in global ... Institute’s 21st Drug & Medical Device Litigation Conference , taking place in New York ... who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and the ...
(Date:12/2/2016)... ... 02, 2016 , ... Advanced Inc., a leading provider of travel therapy and ... to serve as Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason previously ... financial and operational leadership experience to Advanced Inc. He began his career in finance ...
(Date:12/2/2016)... ... December 02, 2016 , ... With the number of pain management programs ... patients must find the one that works for them. When an inventor from Suisun ... that worked and decided to share it with others. , He developed a prototype ...
Breaking Medicine News(10 mins):